Full Description
Since the mid-1990s, a revolution in regards to prescribing antipsychotics has taken place. Once utilized only for schizophrenia, the newer, second generation antipsychotics have now been approved for the treatment of bipolar disorders, depressive disorders, and autism spectrum disorders. They are often utilised elsewhere for the treatment of anxiety disorders, sleep disorders, and to calm agitated patients when dangerous behaviours occur. Prescription rates have soared making them some of the most advertised, prescribed and profitable drugs on the market. This book was developed with input of international authors of varying backgrounds to review the history and development of these agents and to focus on the utilization of these drugs in various disorders, age groups, and clinical situations.
Contents
Preface; AntipsychoticsWe Going?; Second generation antipsychotic medications in the treatment of affective disorders; Antipsychotic Drugs & Children: The Good, the Bad, & What to Do About It; Pharmacokinetic Properties of Second Generation Antipsychotics; Translating Basic Science into Clinical Practice while Dosing the Second Generation Antipsychotics; Depot Antipsychotics; Attitudes toward psychiatric drug treatment in schizophrenia: Socio demographic & illness-related factors; Applying Abstinence, Anticipation, Reduction, & Treatment (AART) for the management of Atypical Antipsychotic Side Effects; Modeling the metabolic side effects of antipsychotics in the male rat; Pharmacogenetics & genomics of antipsychotics-induced weight gain & obesity: An integrated review of the main results; Management of antipsychotic-induced extrapyramidal motor disorders: Regulatory roles of the serotonergic nervous system; Tardive Dyskinesia; Sedating Effects Of Second Generation Antipsychotics; Antipsychotic Side Effects: Identification & Management; Clozapine: Adverse Effects & Their Management; Index.NER(01): GB IE
